Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion type Assertion NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_head.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion description "[Reducing RGS13 and to a lesser extent RGS1 expression in a Burkitt's lymphoma cell line enhances responsiveness to two chemokines, CXC chemokine ligand 12 (CXCL12) and CXCL13, and reducing both mRNAs augments the responses more dramatically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_provenance.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion evidence source_evidence_literature NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_provenance.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion SIO_000772 16565322 NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_provenance.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion wasDerivedFrom befree-20150227 NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_provenance.
- NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_assertion wasGeneratedBy ECO_0000203 NP688141.RAdNJPWtNlDdJNkdut4NGlJh1QMsvcflafqivH-yuN98U130_provenance.